Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0b013e318297593dDOI Listing

Publication Analysis

Top Keywords

pisa syndrome
12
single dose
8
dose mirtazapine
8
acute pisa
4
syndrome administration
4
administration single
4
mirtazapine mirtazapine
4
mirtazapine antidepressant
4
antidepressant adequate
4
adequate safety
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!